First generation anti-CD19 chimeric antigen receptor-modified T cells for management of B cell malignances: initial analysis of an ongoing Phase I clinical trial
| Image |  |
|---|---|
| Description | |
| Author/s |
author: David Gilham Fiona Thistlethwaite |
| Publication date | 2014 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |